Thyrocare Technologies Limited — Regulatory Filings 2018

Aug 24, 2018

Think Thyroid. Think Thyrocare.

==> picture [30 x 352] intentionally omitted <==

ocare Thyr

August 24, 2018

The National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

The Bombay Stock Exchange Ltd Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 001

Dear Sir/Madam,

Sub: Disclosure of information under Regulation 30 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with Investor/ Analyst

==> picture [21 x 7] intentionally omitted <==

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Apurv Kulkarni, Senior Analyst of Nine Rivers Capital Holdings Pvt. Ltd., would be having a meeting with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head- Strategy and Corporate Development, at our office by 2.00 P.M. on Tuesday, August 28, 2018.

There could be last minute change in the timings and Mr. Apurv Kulkarni could be accompanied by one or more of his colleagues/associates.

Please note that no un-published Price-Sensitive Information will be shared during the above meeting.

Yours Faithfully,

For Thyrocare Technologies Limited,

==> picture [53 x 30] intentionally omitted <==

Ramjee Dorai Company Secretary and Compliance Officer

==> picture [84 x 87] intentionally omitted <==

Thyrocare Technologies Limited

9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai - 400 703, India (9 022- 3090 0000 / 4125 2525 m enquiry@thyrocare.com (® www.thyrocare.com

(CIN. L85110MH20 PLC123882